Research Site

Flensburg 24939

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small Cell Lung, Hypercholesterolemia

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment — Completed